0.00
price down icon100.00%   -131.87
after-market Dopo l'orario di chiusura: 131.92 131.92 +
loading

Intra Cellular Therapies Inc Borsa (ITCI) Ultime notizie

pulisher
May 29, 2025

Intra-Cellular Therapies describes new PDE1 inhibitors - BioWorld MedTech

May 29, 2025
pulisher
May 19, 2025

Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Given Consensus Recommendation of “Hold” by Analysts - Defense World

May 19, 2025
pulisher
May 15, 2025

Intra-Cellular Therapies (NASDAQ:ITCI) Now Covered by Analysts at StockNews.com - Defense World

May 15, 2025
pulisher
May 12, 2025

(ITCI) Technical Pivots with Risk Controls - news.stocktradersdaily.com

May 12, 2025
pulisher
May 12, 2025

Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Shares Purchased by Dimensional Fund Advisors LP - Defense World

May 12, 2025
pulisher
May 05, 2025

Dealmaking Quarterly Statistics, Q1 2025 - insights.citeline.com

May 05, 2025
pulisher
Apr 25, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 25, 2025
pulisher
Apr 17, 2025

Trend Tracker for (ITCI) - news.stocktradersdaily.com

Apr 17, 2025
pulisher
Apr 16, 2025

Zynext Ventures Invests in Feldan Therapeutics to Drive Innovation in Intracellular Drug Delivery - Yahoo Finance

Apr 16, 2025
pulisher
Apr 15, 2025

JNJ Tops Q1 Earnings, Ups '25 Sales View to Include Intra-Cellular Deal - TradingView

Apr 15, 2025
pulisher
Apr 15, 2025

Johnson & Johnson Reports Q1 2025 Results - BioSpace

Apr 15, 2025
pulisher
Apr 08, 2025

Intra-Cellular Therapies’ SWOT analysis: acquisition shifts landscape for psychiatric drug stock - Investing.com Canada

Apr 08, 2025
pulisher
Apr 08, 2025

Intra-Cellular Therapies’ SWOT analysis: acquisition shifts landscape for psychiatric drug stock By Investing.com - Investing.com South Africa

Apr 08, 2025
pulisher
Apr 05, 2025

Johnson & Johnson - drugdiscoverytrends.com

Apr 05, 2025
pulisher
Apr 04, 2025

Johnson & Johnson Expects Lower Earnings Impact From Intra-Cellular Therapies Acquisition - MSN

Apr 04, 2025
pulisher
Apr 03, 2025

J&J acquires Intra-Cellular Therapies in multi-billion-dollar deal - ROI-NJ

Apr 03, 2025
pulisher
Apr 03, 2025

J&J to complete acquisition of Intra-Cellular Therapies - Medical Buyer

Apr 03, 2025
pulisher
Apr 03, 2025

Johnson & Johnson buys Bedminster drugmaker for $14.6B - NJBIZ

Apr 03, 2025
pulisher
Apr 03, 2025

JnJ closes Intra-Cellular Therapies acquisition - Medical Dialogues

Apr 03, 2025
pulisher
Apr 02, 2025

JNJ forecasts 2025 profit dilution from Intra-Cellular deal, sets closing date - MSN

Apr 02, 2025
pulisher
Apr 02, 2025

Demystifying Intra-Cellular Therapies: Insights From 6 Analyst Reviews - Benzinga

Apr 02, 2025
pulisher
Apr 02, 2025

Intra-Cellular Therapies acquired by Johnson & Johnson for $14.6 billion - Investing.com South Africa

Apr 02, 2025
pulisher
Apr 02, 2025

Intra-Cellular Therapies Completes Merger with Johnson & Johnson - TipRanks

Apr 02, 2025
pulisher
Apr 02, 2025

Johnson & Johnson acquires Intra-Cellular Therapies By Investing.com - Investing.com South Africa

Apr 02, 2025
pulisher
Apr 02, 2025

Stock Of The Day: Will Johnson & Johnson Rally? The Sell-Off May Have Ended - Benzinga

Apr 02, 2025
pulisher
Apr 02, 2025

Johnson & Johnson Acquires Intra-Cellular Therapies - citybiz

Apr 02, 2025
pulisher
Apr 02, 2025

Johnson & Johnson Closes Landmark Intra-Cellular Therapies, Inc. Acquisition to Solidify Neuroscience Leadership - BioSpace

Apr 02, 2025
pulisher
Apr 02, 2025

Johnson & Johnson Completes Intra-Cellular Therapies Purchase - MarketScreener

Apr 02, 2025
pulisher
Apr 02, 2025

JNJ Completes Acquisition Of Intra-Cellular Therapies - Nasdaq

Apr 02, 2025
pulisher
Apr 02, 2025

Johnson & Johnson acquires Intra-Cellular Therapies - Investing.com

Apr 02, 2025
pulisher
Apr 02, 2025

Johnson & Johnson completes Intra-Cellular Therapies acquisition, sees dilution - TipRanks

Apr 02, 2025
pulisher
Apr 02, 2025

Johnson & Johnson (JNJ) Closes Intra-Cellular Therapies, Inc. (ITCI) Acquisition - StreetInsider

Apr 02, 2025
pulisher
Apr 02, 2025

Johnson & Johnson Expands Its Horizon With Intra-Cellular Therapies Deal - Finimize

Apr 02, 2025
pulisher
Apr 01, 2025

Johnson & Johnson Set To Complete Acquisition Of Intra-Cellular Therapies By April 2, 2025 - Nasdaq

Apr 01, 2025
pulisher
Apr 01, 2025

Johnson & Johnson to finalize Intra-Cellular buyout By Investing.com - Investing.com Canada

Apr 01, 2025
pulisher
Apr 01, 2025

Johnson & Johnson to finalize Intra-Cellular buyout - Investing.com

Apr 01, 2025
pulisher
Apr 01, 2025

Johnson & Johnson Intra-Cellular acquisition to accelerate FY25 sales by 0.8% - TipRanks

Apr 01, 2025
pulisher
Apr 01, 2025

Johnson & Johnson (JNJ) Sets April 2nd as Expected Closing Date for Intra-Cellular Acquisition - StreetInsider

Apr 01, 2025
pulisher
Apr 01, 2025

Johnson & Johnson Announces Expected Closing Date for Intra-Cellular Acquisition - The Joplin Globe

Apr 01, 2025
pulisher
Apr 01, 2025

Intra-cellular Therapeutics Surges to 322nd in Trading Volume Ranking with 3.36 Billion Shares Exchanged - AInvest

Apr 01, 2025
pulisher
Mar 31, 2025

(ITCI) On The My Stocks Page - news.stocktradersdaily.com

Mar 31, 2025
pulisher
Mar 28, 2025

Intra-cellular Therapies Surges to 340th in Daily Rankings with 2.46 Billion Turnover - AInvest

Mar 28, 2025
pulisher
Mar 27, 2025

Intra-Cellular Therapies Stock Hits All-Time High of $131.79 By Investing.com - Investing.com South Africa

Mar 27, 2025
pulisher
Mar 27, 2025

Intra-Cellular Therapies Shareholders Approve Johnson & Johnson Merger - Investing.com

Mar 27, 2025
pulisher
Mar 27, 2025

Intra-Cellular Therapies Shareholders Approve Johnson & Johnson Merger By Investing.com - Investing.com Australia

Mar 27, 2025
pulisher
Mar 27, 2025

Beam Therapeutics (BEAM) Down 21.4% Since Last Earnings Report: Can It Rebound? - Yahoo Finance

Mar 27, 2025
pulisher
Mar 27, 2025

Intra-Cellular Therapies Stock Hits All-Time High of $131.79 - Investing.com

Mar 27, 2025
pulisher
Mar 27, 2025

Intra-Cellular Therapies: These Are 5 Critical Challenges Threatening Its Expansion Plans! - Smartkarma

Mar 27, 2025
pulisher
Mar 19, 2025

Intra-Cellular Therapies announces proxy statement supplement By Investing.com - Investing.com South Africa

Mar 19, 2025
$318.85
price down icon 0.47%
drug_manufacturers_specialty_generic RDY
$14.72
price down icon 0.20%
$123.02
price down icon 0.52%
drug_manufacturers_specialty_generic HCM
$13.89
price up icon 0.22%
drug_manufacturers_specialty_generic RGC
$877.00
price up icon 18.36%
$16.78
price down icon 4.28%
Capitalizzazione:     |  Volume (24 ore):